560 related articles for article (PubMed ID: 29976769)
1. Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
Haghikia A; Li XS; Liman TG; Bledau N; Schmidt D; Zimmermann F; Kränkel N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Fraccarollo D; Heimesaat MM; Bauersachs J; Wang Z; Zhu W; Bavendiek U; Hazen SL; Endres M; Landmesser U
Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2225-2235. PubMed ID: 29976769
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota-Dependent Trimethylamine N-oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS-TIMI 54 Trial.
Gencer B; Li XS; Gurmu Y; Bonaca MP; Morrow DA; Cohen M; Bhatt DL; Steg PG; Storey RF; Johanson P; Wang Z; Hazen SL; Sabatine MS
J Am Heart Assoc; 2020 May; 9(10):e015331. PubMed ID: 32366163
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Li XS; Obeid S; Klingenberg R; Gencer B; Mach F; Räber L; Windecker S; Rodondi N; Nanchen D; Muller O; Miranda MX; Matter CM; Wu Y; Li L; Wang Z; Alamri HS; Gogonea V; Chung YM; Tang WH; Hazen SL; Lüscher TF
Eur Heart J; 2017 Mar; 38(11):814-824. PubMed ID: 28077467
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
[TBL] [Abstract][Full Text] [Related]
6. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.
Tang WH; Wang Z; Levison BS; Koeth RA; Britt EB; Fu X; Wu Y; Hazen SL
N Engl J Med; 2013 Apr; 368(17):1575-84. PubMed ID: 23614584
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide.
Wang Z; Tang WH; Buffa JA; Fu X; Britt EB; Koeth RA; Levison BS; Fan Y; Wu Y; Hazen SL
Eur Heart J; 2014 Apr; 35(14):904-10. PubMed ID: 24497336
[TBL] [Abstract][Full Text] [Related]
8. Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke.
Zhang J; Wang L; Cai J; Lei A; Liu C; Lin R; Jia L; Fu Y
J Neuroimmunol; 2021 May; 354():577526. PubMed ID: 33647820
[TBL] [Abstract][Full Text] [Related]
9. Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism.
Obeid R; Awwad HM; Rabagny Y; Graeber S; Herrmann W; Geisel J
Am J Clin Nutr; 2016 Mar; 103(3):703-11. PubMed ID: 26864355
[TBL] [Abstract][Full Text] [Related]
10. Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study.
Tang WHW; Li XS; Wu Y; Wang Z; Khaw KT; Wareham NJ; Nieuwdorp M; Boekholdt SM; Hazen SL
Am Heart J; 2021 Jun; 236():80-86. PubMed ID: 33626384
[TBL] [Abstract][Full Text] [Related]
11. Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events.
Kim RB; Morse BL; Djurdjev O; Tang M; Muirhead N; Barrett B; Holmes DT; Madore F; Clase CM; Rigatto C; Levin A;
Kidney Int; 2016 May; 89(5):1144-1152. PubMed ID: 27083288
[TBL] [Abstract][Full Text] [Related]
12. Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.
Haissman JM; Haugaard AK; Ostrowski SR; Berge RK; Hov JR; Trøseid M; Nielsen SD
BMC Infect Dis; 2017 Jun; 17(1):445. PubMed ID: 28645263
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Plasma Trimethylamine N-Oxide Levels in Patients with Acute Ischemic Stroke.
Zhai Q; Wang X; Chen C; Tang Y; Wang Y; Tian J; Zhao Y; Liu X
Cell Mol Neurobiol; 2019 Nov; 39(8):1201-1206. PubMed ID: 31332666
[TBL] [Abstract][Full Text] [Related]
14. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
[TBL] [Abstract][Full Text] [Related]
15. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-
Cho CE; Aardema NDJ; Bunnell ML; Larson DP; Aguilar SS; Bergeson JR; Malysheva OV; Caudill MA; Lefevre M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722424
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis.
Witkowski M; Witkowski M; Friebel J; Buffa JA; Li XS; Wang Z; Sangwan N; Li L; DiDonato JA; Tizian C; Haghikia A; Kirchhofer D; Mach F; Räber L; Matter CM; Tang WHW; Landmesser U; Lüscher TF; Rauch U; Hazen SL
Cardiovasc Res; 2022 Jul; 118(10):2367-2384. PubMed ID: 34352109
[TBL] [Abstract][Full Text] [Related]
17. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
[TBL] [Abstract][Full Text] [Related]
18. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Changes in Gut Microbiota-Derived Metabolite Trimethylamine-N-Oxide and Risk of Type 2 Diabetes Mellitus: Potential for Dietary Changes in Diabetes Prevention.
Huang Y; Wu Y; Zhang Y; Bai H; Peng R; Ruan W; Zhang Q; Cai E; Ma M; Zhao Y; Lu Y; Zheng L
Nutrients; 2024 May; 16(11):. PubMed ID: 38892643
[TBL] [Abstract][Full Text] [Related]
20. Increased Trimethylamine N-Oxide Portends High Mortality Risk Independent of Glycemic Control in Patients with Type 2 Diabetes Mellitus.
Tang WH; Wang Z; Li XS; Fan Y; Li DS; Wu Y; Hazen SL
Clin Chem; 2017 Jan; 63(1):297-306. PubMed ID: 27864387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
